Bavarian Nordic indgår kontrakt med det amerikanske forsvar om udvikling af vaccine mod alphavirus
March 16, 2018 08:53 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Aftalen har en værdi af op til USD 36 mio. ...
Bavarian Nordic tildeler betingede aktier til selskabets ledelse
March 12, 2018 02:55 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 12. marts 2018 - Bavarian...
Bavarian Nordic Awards Restricted Stock Units to Executive Management
March 12, 2018 02:55 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, March 12, 2018 -...
Bavarian Nordic offentliggør årsrapport for 2017
March 12, 2018 02:40 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 12. marts 2018 -...
Bavarian Nordic Announces Annual Report 2017
March 12, 2018 02:40 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, March 12, 2018...
Bavarian Nordic offentliggør nyt fase 2 kombinationsforsøg med CV301 og nivolumab i tyktarmskræft
March 08, 2018 08:58 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Bavarian Nordic og Bristol-Myers Squibb...
Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer
March 08, 2018 08:58 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Bavarian Nordic and Bristol-Myers Squibb...
Bavarian Nordic afholder telefonkonference i forbindelse med offentliggørelse af årsregnskabet for 2017
March 07, 2018 11:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, 7. marts 2018 - Bavarian Nordic A/S...
Bavarian Nordic to Host Full Year 2017 Results Conference Call
March 07, 2018 11:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark - March 7, 2018 -...
Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine
March 06, 2018 08:32 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Presence of antibodies in nasal mucosa...